Welcome to CSNpharm! For Research Use Only!
ULK
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN16884 | SBI-0206965 | 1884220-36-3 | SBI-0206965 is a potent selective and cell permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for the highly related kinase ULK2 |
| CSN19225 | N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride(1:x) | 2599216-02-9 | MRT68921·xHCl is a potent and dual autophagy kinase ULK1/2 inhibitor with IC50 of 2.9 nM and 1.1 nM, respectively. |
| CSN18901 | MRT68921 HCl | 2070014-87-6 | MRT68921 HCl is a selective inhibitor of ULK1 and ULK2 with IC50 0f 2.9 nM and 1.1 nM. |
| CSN23238 | MRT68921 dihydrochloride | 2080306-21-2 | MRT68921 dihydrochloride is the most potent inhibitor of ULK1 and ULK2, with IC50 values of 2.9 nM and 1.1 nM, respectively. |
| CSN21387 | LYN-1604 | 2088939-99-3 | LYN-1604 is a potent UNC-51-like kinase 1 ULK1 agonist with an EC50 of 1894 nM |
| CSN22251 | LYN-1604 hydrochloride | 2216753-86-3 | LYN-1604 HCl is an agonist of ULK1 with EC50 of 1894 nM |
| CSN26792 | LYN-1604 dihydrochloride | 2310109-38-5 | LYN-1604 dihydrochloride is a potent UNC-51-like kinase 1 (ULK1) activator (EC50=18.94 nM) for the research of triple negative breast cancer (TNBC)[1]. |
| CSN24061 | ULK-101 | 2443816-45-1 | LK-101 is a potent and selective ULK1 inhibitor with in vitro IC50 of 8.3 nM. |
| CSN25576 | BL-918 | 2101517-69-3 | BL-918 is an orally active UNC-51-like kinase 1 (ULK1) activator with an EC50 of 24.14 nM. BL-918 induces cytoprotective autophagy for Parkinson's disease treatment. |
| CSN27829 | SBP-7455 | 1884222-74-5 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
